BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 7524945)

  • 1. High-dose intraperitoneal aprotinin treatment of acute severe pancreatitis: a double-blind randomized multi-center trial.
    Berling R; Genell S; Ohlsson K
    J Gastroenterol; 1994 Aug; 29(4):479-85. PubMed ID: 7524945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peritoneal lavage with aprotinin in patients with severe acute pancreatitis. Effects on plasma and peritoneal levels of trypsin and leukocyte proteases and their major inhibitors.
    Berling R; Borgström A; Ohlsson K
    Int J Pancreatol; 1998 Aug; 24(1):9-17. PubMed ID: 9746884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of high-dose intraperitoneal aprotinin treatment on complement activation and acute phase response in acute severe pancreatitis.
    Berling R; Ohlsson K
    J Gastroenterol; 1996 Oct; 31(5):702-9. PubMed ID: 8887038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue kallikrein in severe acute pancreatitis in patients treated with high-dose intraperitoneal aprotinin.
    Bläckberg M; Berling R; Ohlsson K
    Pancreas; 1999 Nov; 19(4):325-34. PubMed ID: 10547191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra-peritoneal aprotinin therapy for acute pancreatitis. Preliminary pharmacodynamic studies.
    Larvin M; Mayer AD; McMahon MJ; Müller-Esterl W; Fritz H
    Biol Chem Hoppe Seyler; 1988 May; 369 Suppl():149-52. PubMed ID: 2462429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gabexate mesilate vs aprotinin in human acute pancreatitis (GA.ME.P.A.). A prospective, randomized, double-blind multicenter study.
    Pederzoli P; Cavallini G; Falconi M; Bassi C
    Int J Pancreatol; 1993 Oct; 14(2):117-24. PubMed ID: 7506742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of peritoneal dialysis with and without aprotinin on acute experimental pancreatitis in rats.
    Tilquin BM; O'Connor TC; Hancotte-La Haye CM; Gonze DM; Reynaert MS; De Muylder CG; Kestens PJ
    Int Surg; 1990; 75(3):174-8. PubMed ID: 1700770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single-centre double-blind trial of Trasylol therapy in primary acute pancreatitis.
    Imrie CW; Benjamin IS; Ferguson JC; McKay AJ; Mackenzie I; O'Neill J; Blumgart LH
    Br J Surg; 1978 May; 65(5):337-41. PubMed ID: 348250
    [No Abstract]   [Full Text] [Related]  

  • 9. Death from acute pancreatitis. M.R.C. multicentre trial of glucagon and aprotinin.
    Lancet; 1977 Sep; 2(8039):632-5. PubMed ID: 71449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morbidity of acute pancreatitis: the effect of aprotinin and glucagon.
    Gut; 1980 Apr; 21(4):334-9. PubMed ID: 6159256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of aprotinin (Trasylol) on experimental acute necrosis of the pancreas in rats.
    Dembińska-Kieć A
    Acta Med Pol; 1972; 13(1):1-28. PubMed ID: 4544454
    [No Abstract]   [Full Text] [Related]  

  • 12. A double-blind controlled clinical trial of Trasylol. Preliminary results in acute pancreatitis and in prophylaxis against postoperative pancreatitis.
    Baden H; Jordal K; Lund F; Zachariae F
    Acta Chir Scand Suppl; 1967; 378():97-102. PubMed ID: 4866570
    [No Abstract]   [Full Text] [Related]  

  • 13. Prophylactic and curative action of Trasylol in pancreatitis. A double-blind trial.
    Baden H; Jordal K; Lund F; Zachariae F
    Scand J Gastroenterol; 1969; 4(3):291-5. PubMed ID: 4899636
    [No Abstract]   [Full Text] [Related]  

  • 14. [Trasylol treatment of acute pancreatitis. A double-blind study].
    Storck G; Persson B
    Nord Med; 1968 May; 79(20):651-3. PubMed ID: 4872515
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of peritoneal lavage and aprotinin in the treatment of severe acute pancreatitis.
    Balldin G; Borgström A; Genell S; Ohlsson K
    Res Exp Med (Berl); 1983; 183(3):203-13. PubMed ID: 6196821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous peritoneal dialysis in acute experimental pancreatitis in dogs. Effect of aprotinin in the dialysate medium.
    Bassi C; Briani G; Vesentini S; Orcalli F; Falconi M; Vantini I; Cavallini G; Maffezzoli G; Pederzoli P
    Int J Pancreatol; 1989 Jul; 5(1):69-75. PubMed ID: 2473149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment of a matrix metalloproteases inhibitor and aprotinin attenuated the development of acute pancreatitis-induced lung injury in rat model.
    Chu KE; Fong Y; Wang D; Chen CF; Yeh DY
    Immunobiology; 2018 Jan; 223(1):64-72. PubMed ID: 29030007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative clinical study of FOY and Trasylol in acute pancreatitis.
    Tanaka N; Tsuchiya R; Ishii K
    Adv Exp Med Biol; 1979; 120B():367-78. PubMed ID: 229707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Dextran 40 and aprotinin on experimental acute pancreatitis.
    Crocket KV; Reising JR; Wirman JA; Gau N; Joffe SN
    J Surg Res; 1984 Mar; 36(3):256-64. PubMed ID: 6199589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intraperitoneal administration of trasylol as an attempt at treatment of acute pancreatitis].
    Suszczewska-Fischerowa I
    Pol Przegl Chir; 1972 Mar; 44(3):483-95. PubMed ID: 4536985
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.